Specifically, both WNT5A and WNT5B are overexpressed in non-small cell lung cancers (NSCLC) compared to normal tissue and their overexpression is correlated with poor overall survival (Huang et al., 2005; Zhang et al., 2020). Here, WNT5B is linked to non-small cell lung carcinoma.